Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1

The authors report on an open-label study of an MF59-adjuvanted vaccine against avian influenza. The findings indicate that priming subjects with H5 antigen induces a rapidly mobilized, long-lasting immune memory after the administration of low-dose, antigenically distinct vaccine.